Home/Filings/4/0001179110-21-007283
4//SEC Filing

LIDDY EDWARD M 4

Accession 0001179110-21-007283

CIK 0001551152other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 9:09 AM ET

Size

5.7 KB

Accession

0001179110-21-007283

Insider Transaction Report

Form 4
Period: 2021-06-30
Transactions
  • Award

    Stock Equivalent Units

    2021-06-30$112.67/sh+284$31,99826,944 total
    Exercise: $112.67Common Stock (284 underlying)
Footnotes (2)
  • [F1]Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The cash equivalent of 1,748 stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on May 1, 2021. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
  • [F2]Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001188983

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:09 AM ET
Size
5.7 KB